Latest News

Mutant-Allele Tumor Heterogeneity (MATH) in head, neck squamous cell carcinoma patients is effective marker, along with HPV status, of improved patient outcome

Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient?s HPV status provides an effective indicator of improved patient outcome, according to research.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Autism: Change schools -- not students -- for more inclusive education

  • Self-expanding transcatheter aortic valve reduces risk of major stroke and early death

  • Slow to mature, quick to distract: ADHD brain study finds slower development of key connections

  • Combining epilepsy drug, morphine can result in less pain, lower opioid doses

  • Concussions: 'Hidden injury' in sports

  • Neuroscientists identify key role of language gene

  • Number-crunching could lead to unethical choices, says new study

  • Researcher develops, proves effectiveness of new drug for spinal muscular atrophy

  • EEG study findings reveal how fear is processed in the brain

  • Brain scans used to forecast early reading difficulties

  •